Development of Classification Models for Identifying “True” P-glycoprotein (P-gp) Inhibitors Through Inhibition, ATPase Activation and Monolayer Efflux Assays

By Rapposelli Simona   Coi Alessio   Imbriani Marcello   Bianucci Anna Maria  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-06 ,pp. : 6924-6943

MDPI

Access to resources Recommend Favorite

Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition

By Dewanjee Saikat   K. Dua Tarun   Bhattacharjee Niloy   Das Anup   Gangopadhyay Moumita   Khanra Ritu   Joardar Swarnalata   Riaz Muhammad   De Feo Vincenzo   Zia-Ul-Haq Muhammad  

Molecules, Vol. 22, Iss. 6, 2017-05 ,pp. : 871-871

MDPI

Access to resources Recommend Favorite

Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells

By Wang Yunshan   Ma Guangxin   Wang Qin   Wen Mingxin   Xu Yangyang   He Xiuquan   Zhang Pengju   Wang Yuli   Yang Taomei   Zhan Panpan   Wei Guangwei  

Molecules, Vol. 19, Iss. 1, 2013-12 ,pp. : 159-176

MDPI

Access to resources Recommend Favorite

Novel Natural Inhibitors of CYP1A2 Identified by in Silico and in Vitro Screening

By Zhu Ruixin   Hu Liwei   Li Haiyun   Su Juan   Cao Zhiwei   Zhang Weidong  

International Journal of Molecular Sciences, Vol. 12, Iss. 5, 2011-05 ,pp. : 3250-3262

MDPI

Access to resources Recommend Favorite

Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition

By Hunyadi Attila   Csábi József   Martins Ana   Molnár Joseph   Balázs Attila   Tóth Gábor  

Molecules, Vol. 22, Iss. 2, 2017-01 ,pp. : 199-199

MDPI

Access to resources Recommend Favorite